Evidence map›Paper›PMID 32471458›Full record

ArticleJournal of orthopaedic surgery and research2020

The study of targeted blocking SDF-1/CXCR4 signaling pathway with three antagonists on MMPs, type II collagen, and aggrecan levels in articular cartilage of guinea pigs.

Guoliang Wang, Yanlin Li, Xuhan Meng, Xiao Yang, Yaoyu Xiang

Open access · goldAbstract read
In one paragraph

Article in Journal of orthopaedic surgery and research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Guoliang WangDepartment of Sports Medicine, First Affiliated Hospital of Kunming Medical University, No.295 Xichang Road, Kunming, 650031, Yunnan, China.
Yanlin LiDepartment of Sports Medicine, First Affiliated Hospital of Kunming Medical University, No.295 Xichang Road, Kunming, 650031, Yunnan, China. 852387873@qq.com.
Xuhan MengDepartment of Sports Medicine, First Affiliated Hospital of Kunming Medical University, No.295 Xichang Road, Kunming, 650031, Yunnan, China.
Xiao YangDepartment of Sports Medicine, First Affiliated Hospital of Kunming Medical University, No.295 Xichang Road, Kunming, 650031, Yunnan, China.
Yaoyu XiangDepartment of Sports Medicine, First Affiliated Hospital of Kunming Medical University, No.295 Xichang Road, Kunming, 650031, Yunnan, China.
Kunming Medical University · CNFirst Affiliated Hospital of Kunming Medical University · CN

Funding

National Natural Science Foundation of China 30860286National Natural Science Foundation of China 81960409
6 · The paper itself

Abstract

objectiveTo explore the possibility and mechanism of targeted blocking SDF-1/CXCR4 signaling pathway using three antagonists TN14003, T140, and AMD3100 in vivo, and to investigate the function of three antagonists in delay degeneration process of articular cartilage.

methodsNinety-six male Duncan-Hartley guinea pigs (6 months old) were divided into groups A, B, C, and D randomly. Alzet trace pump was implanted in the back subcutaneous tissue of pigs in group A, and TN14003 with concentration of 180 μg/ml was pumped every day. Alzet trace pump was implanted in the back subcutaneous tissue of pigs in group B, and T140 with concentration of 180 μg/ml was pumped every day. Alzet trace pump was implanted in the back subcutaneous tissue of pigs in group C, and AMD3100 with concentration of 180 μg/ml was pumped every day. Hartley guinea pigs in group D remained untreated as the blank control group. At 2, 4, 6, 8, 10, and 12 weeks of treatment, 5 to 8 animals in each group were randomly chosen for blood collection via cardiac puncture. SDF-1 content using enzyme-linked immunosorbent assay (ELISA). At 12 weeks, all guinea pigs were sacrificed by injecting pentobarbital sodium (30 mg/kg) into the peritoneal cavity. Cartilages from the tibial plateau in each group were harvested for PCR testing and western blot analysis. SPSS19.0 was used for data analysis.

resultsResult of ELISA: the serum levels of SDF-1 of groups A, B, and C decreased gradually with time. Significant drop of SDF-1 level was seen in group A while increased SDF-1 was shown in group D. At the same time, the serum levels of SDF-1 of the group A were significantly lower than that of group B; those of group B were significantly lower than that of group C, which was significantly lower than that of group D, and their difference is statistically significant (P < 0.05). Real time quantitative PCR result: The mRNA levels of MMPs in group A were significantly lower than group B, and those of group B were significantly lower than group C, which was significantly lower than group D, and there was statistically significant (P < 0.05). The mRNA levels of type II collagen, aggrecan in group A were significantly more than group B; those of group B were significantly more than group C, which was significantly more than group D, and the difference was statistically significant (P < 0.05). H&E staining result: cartilage of group C was more significantly degenerative than other groups.

conclusionsThe three antagonists can target SDF-1/CXCR4 signaling pathway in vivo, reduce the expression and secretion of MMP-3, MMP-9, and MMP-13 in cartilage tissue, and reduce the degradation of collagen II and aggregating proteoglycan, thus delaying the degeneration of articular cartilage, of which TN14003 has the strongest regulatory effect. Targeted blockade of SDF-1/CXCR4 signaling pathway by TN14003 in vivo delays articular cartilage degeneration more effectively than T140 and AMD3100.

Indexed as

Signal TransductionAggrecansAnimalsBenzylaminesCartilageCartilage, ArticularChemokine CXCL12CyclamsGuinea PigsMaleMatrix MetalloproteinasesOligopeptidesPeptidesReceptors, CXCR4AggrecansBenzylaminesChemokine CXCL12CyclamsMatrix MetalloproteinasesOligopeptidesPeptidesplerixaforReceptors, CXCR4T140 peptideTN14003ChondrocyteMatrix metalloproteinaseOsteoarthritisStromal cell derived factor-1(SDF-1)

Identifiers

PMID32471458
PMCPMC7257224
OpenAlexW3032712063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.